Ciprofloxacin in the treatment of Staphylococcus aureus osteomyelitis a review
- 1 March 1990
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 13 (2), 169-171
- https://doi.org/10.1016/0732-8893(90)90103-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospitalAntimicrobial Agents and Chemotherapy, 1989
- Efficacy, Safety, and Potential Economic Benefits of Oral Ciprofloxacin in the Treatment of InfectionsClinical Infectious Diseases, 1988
- Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacinAntimicrobial Agents and Chemotherapy, 1987
- Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Ciprofloxacin concentrations in bone and muscle after oral dosingAntimicrobial Agents and Chemotherapy, 1986
- Effect of ciprofloxacin on phagocytosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985
- Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactionsAntimicrobial Agents and Chemotherapy, 1985
- In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agentAntimicrobial Agents and Chemotherapy, 1984
- Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- Osteomyelitis in Infants and ChildrenAmerican Journal of Diseases of Children, 1975